Cuadrado-Lavín, Antonio
Olmos, José Manuel
Cifrian, José Manuel
Gimenez, Teresa
Gandarillas, Marco Antonio
García-Saiz, Mar
Rebollo, Maria Henar
Martínez-Taboada, Victor
López-Hoyos, Marcos
Fariñas, María Carmen
Crespo, Javier
Article History
Received: 7 May 2020
Accepted: 9 May 2020
First Online: 3 June 2020
Ethics approval and consent to participate
: This trial has been approved by the Ethics and Drug Research Committee of Cantabria (CEIm-Cantabria) dated April 24, 2020 (act. 6/2020).We certify that this trial has received ethical approval from the appropriate ethical committee as described above.The corresponding written Informed Consent will be obtained from all participants.
: Not applicable.
: JC reports grant support and/or consultancy and lecture fees from AbbVie, Gilead Sciences, Bristol-Myers Squibb, Janssen and MSD. The rest of the authors declare that they have no competing interests.